236 related articles for article (PubMed ID: 34019805)
41. Genomics, personalized medicine, and supportive cancer care.
Sonis ST
Am Soc Clin Oncol Educ Book; 2015; ():9-16. PubMed ID: 25993135
[No Abstract] [Full Text] [Related]
42. Cancer pharmacogenomics.
Paugh SW; Stocco G; McCorkle JR; Diouf B; Crews KR; Evans WE
Clin Pharmacol Ther; 2011 Sep; 90(3):461-6. PubMed ID: 21796115
[TBL] [Abstract][Full Text] [Related]
43. Precision Oncology: Are We There Yet?
EBioMedicine; 2017 Apr; 18():1-2. PubMed ID: 28442127
[No Abstract] [Full Text] [Related]
44. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
45. Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model.
Goetz MP; Ames MM; Weinshilboum RM
Mayo Clin Proc; 2004 Mar; 79(3):376-84. PubMed ID: 15008610
[TBL] [Abstract][Full Text] [Related]
46. Precision in cancer pharmacogenomics.
Kyrochristos ID; Baltagiannis EG; Mitsis M; Roukos DH
Pharmacogenomics; 2020 Apr; 21(5):311-316. PubMed ID: 32242500
[No Abstract] [Full Text] [Related]
47. The Promise of Pharmacogenomics: Genetic variation can be used to individualize drug therapy, and is an integral component of genomic medicine.
Am J Med Genet A; 2019 Dec; 179(12):2324-2325. PubMed ID: 31709748
[No Abstract] [Full Text] [Related]
48. Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.
Blix A
Clin J Oncol Nurs; 2014 Aug; 18(4):437-41. PubMed ID: 25095297
[TBL] [Abstract][Full Text] [Related]
49. Lack Of Diversity In Genomic Databases Is A Barrier To Translating Precision Medicine Research Into Practice.
Landry LG; Ali N; Williams DR; Rehm HL; Bonham VL
Health Aff (Millwood); 2018 May; 37(5):780-785. PubMed ID: 29733732
[TBL] [Abstract][Full Text] [Related]
50. Pharmacogenomics, precision medicine, and implications for anesthesia care.
Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
[TBL] [Abstract][Full Text] [Related]
51. Implementing a personalized medicine cancer program in a community cancer system.
Dressler LG; Bell GC; Schuetze DP; Steciuk MR; Binns OA; Raab RE; Abernathy PM; Wilson CM; Kunutsor SE; Loveless MC; Ahearne PM; Messino MJ
Per Med; 2019 May; 16(3):221-232. PubMed ID: 31109249
[No Abstract] [Full Text] [Related]
52. Evidence-Based Precision Oncology with the Cancer Targetome.
Blucher AS; Choonoo G; Kulesz-Martin M; Wu G; McWeeney SK
Trends Pharmacol Sci; 2017 Dec; 38(12):1085-1099. PubMed ID: 28964549
[TBL] [Abstract][Full Text] [Related]
53. Value of Supportive Care Pharmacogenomics in Oncology Practice.
Patel JN; Wiebe LA; Dunnenberger HM; McLeod HL
Oncologist; 2018 Aug; 23(8):956-964. PubMed ID: 29622698
[TBL] [Abstract][Full Text] [Related]
54. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
55. Apply Resources to Practice: Use Current Genetics and Genomics Content in Oncology.
Mahon SM
Clin J Oncol Nurs; 2017 Feb; 21(1):34-38. PubMed ID: 28107338
[TBL] [Abstract][Full Text] [Related]
56. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
Nagy M; Attya M; Patrinos GP
Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
[TBL] [Abstract][Full Text] [Related]
57. Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.
Lee JK; Liu Z; Sa JK; Shin S; Wang J; Bordyuh M; Cho HJ; Elliott O; Chu T; Choi SW; Rosenbloom DIS; Lee IH; Shin YJ; Kang HJ; Kim D; Kim SY; Sim MH; Kim J; Lee T; Seo YJ; Shin H; Lee M; Kim SH; Kwon YJ; Oh JW; Song M; Kim M; Kong DS; Choi JW; Seol HJ; Lee JI; Kim ST; Park JO; Kim KM; Song SY; Lee JW; Kim HC; Lee JE; Choi MG; Seo SW; Shim YM; Zo JI; Jeong BC; Yoon Y; Ryu GH; Kim NKD; Bae JS; Park WY; Lee J; Verhaak RGW; Iavarone A; Lee J; Rabadan R; Nam DH
Nat Genet; 2018 Oct; 50(10):1399-1411. PubMed ID: 30262818
[TBL] [Abstract][Full Text] [Related]
58. Pharmacogenomics and individualized medicine: translating science into practice.
Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
[TBL] [Abstract][Full Text] [Related]
59. Precision medicine: a call for increased pharmacogenomic education.
Ta R; Cayabyab MA; Coloso R
Per Med; 2019 May; 16(3):233-245. PubMed ID: 31025601
[TBL] [Abstract][Full Text] [Related]
60. Evolving Paradigms of Personalized Medicine in Oncology.
Dhingra K
Natl Med J India; 2017; 30(6):305-308. PubMed ID: 30117439
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
